Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Expert Opinion / Cases · December 21, 2022

HR−/HER2+ Local Breast Cancer Diagnosed During the Treatment for HR+/HER2− Metastatic Breast Cancer

Written by
Jing Xi MD, MPH


Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Chris Mckay

    Dec 22, 2022

    I am wondering if this was lobular mets.? It wouldn't change treatment but would be good information to have. Also if genomic testing might be useful to see if other treatments might be advised.

  • May 30, 2024

    Pending Moderator approval.

Further Reading